program

July 5

at 09.00-11.30 Round table

Liver transplantation: Ethics, Organization, Innovation, Perspectives

presentation Mariano Quartini, Maria Oliva Thought

moderator Michele Cucuzza

**Alessandro Nanni Costa **Director of the National Transplant Center.

**Atanassios Dovas **Responsible for Umbria Regional Transplant Center.

Marco Vivarelli Director of Transplant Surgery - Ancona

**Marinella Zanierato **Local Organ Donation Coordinator - Pavia

**Fabrizio Soccorsi **Pontiff Clinic.

**Fabio Ermili **Surgeon - Foligno

**Gianni Giovannini **Health Planning Manager Umbria Region.

Attilio Solinas President Health Commission Umbria Region

Vittorio Pulcinelli Umbria regional president AIDO

**Lucio Lisarelli **Transplant patient.

at 11.45 Introduction - Introduction M. Quartini, M.o. Think .

I SESSION: Acute liver failure.

chairman D. Francisci

moderators P. M. Brunori, G. Bassotti

at 12.15 Hepatitis from xenobiotic drugs to.Grieco

at 12.30 Acute viral hepatitis** P. Carrai**

at 12.45 Acute over chronic liver failure P. Caraceni

at 13.00 Discussion

at 1:30 p.m. Lunch

II SESSION: Decompensated cirrhosis (1)

president to. Benedetti

moderators G. Passalacqua, F. Farroni

at 14.45 The management of complications: ascites and SER P. Angeli

at 15.00 The management of complications: hepatic encephalopathy S. Montagnese

at 15.15 The management of complications: sangunamento from varices and ...TIPS O. Riggio

at 15.30 The alcoholic hepatopathy G.M. Testino

at 15.50 Discussion

at 16.10 Coffee Break

III SESSION: Decompensated cirrhosis (2)

president C. Clerici

moderators V. Pace Palitti, R. Colucci

at 16.25 The management of CBP and new therapeutic opportunities P. Invernizzi

at 16.40 Treatment of HCV in decompensated cirrhosis** to. Craxi**

at 16.55 Guidelines on nutritional status in the cirrhotic patient** M. Merli**

at 17.10 The timing of the referral M. Angelico

at 17.25 Discussion

at 6:00 p.m. Closing of the first day

July 6

IV SESSION: HCC

president L. Bolondi

moderators M. Costa, S. Fiorucci

at 8.45 The 2018 EASL Guidelines** M. Colombo**

at 09.00 Down staging treatment: ablations, TACE, SIRT L. Crocetti

at 09.15 The surgical treatment and referral M. Vivarelli

at 09.30 Discussion

SESSION V: The Posttransplantation

president G. Ceccarelli

moderators O. Morelli, U. Vespasiani Gentilucci

at 10.00 The infectious risk M. Puoti

at 10.15 The de novo pathologies: autoimmune hepatitis** D. Vergari**

at 10.30 Viral relapse prophylaxis and therapy R. Volpes

at 11.00 Discussion

at 11.15 Coffee break

SESSION VI: Perspectives

president G.M. Ettorre

moderators to. Izzi, F. Tarsetti

at 11.30 How the indications for transplantation will change M. Marzoni

at 11.45 The transplantation of oncology U. Cillo

at 12.00 Can the indication for transplantation in alcoholic hepatopathy be extended?** P. Burra**

at 12.15 New horizons in liver graft preservation** P. Muiesan**

at 12.30 Discussion

EPATEAM PROJECT: Interaction between transplant and territorial centers.

at 12.45 The pre-transplant pathway M. Rendina

at 13.00 Late complications** L. Caccamo**

at 13.15 The management of immunosuppressive therapy** P. De Simone**

at 13.30 Discussion

at 1:45 pm Conclusions

at 2:00 p.m. Lunch

SATELLITE MEETING

Focus On HCV: Governance Today and Tomorrow

moderators **G. Snowdrop, F. Di Candilo **

at 15.30 Introduction M.O. Pensi, M.Quartini

at 15.40 Treatments and costs: how they have changed D. Francisci, M. Rossi

at 16.00 Experience of a transplant center on the impact of treatment on transplant waiting lists P. Carrai

at 16.15 Investing today to save money and improve health tomorrow to. Gasbarrini

at 16.30 Is screening in HCV feasible? to. Solinas

at 16.45 Possible strategies to increase the diagnosis of from HCV infection in the general population: a model for elimination based on data from the PITER cohort** L. Kondili**

at 17.00 The approach to patients with addictions F. to. Nava

at 17.15 Discussion

at 17.30 ROUND TABLE : HCV and Linkage to care

participate:

**M. Angeli **(SERD Narni) - **M. Cuccuini **(SERD Terni)

F. Di Candilo (Mal.Inf. PG) - C. Di Giuli (Mal.Inf. TR)

G. Dozzini (SERD Foligno) - **F. Gentili **( Hepatology Terni)

E.Mancini (La Tenda Foligno Community)

M. Marchino (Orvieto SERD) - to. Marozzo (TR Prison) **P. Pierucci **(Community Meeting Amelia) - to. Rossi (Narni GP)

at 19.00 Conclusions

Closing Conference and CME Test

Hepatology, is experiencing significant and extraordinary changes. This is the context for the Conference _Future Scenarios in Hepatology _which is being held for the second year during the Festival's programming.